Insular lesions and smoking cessation after first-ever ischemic stroke: A 3-month follow-up

Neuroscience Letters

Volumn 478, Issue 3, 2010, Pages 161-164

  Bienkowski, Przemyslaw ^a   Zatorski, Pawel ^a   Baranowska, Anna ^a   Ryglewicz, Danuta ^a   Sienkiewicz Jarosz, Halina ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Insula; Ischemic stroke; Lesion localization; Smoking cessation

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; BRAIN STEM; CAPSULA INTERNA; CORPUS STRIATUM; FEMALE; FOLLOW UP; HUMAN; INSULA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; STROKE; THALAMUS; TISSUE DISTRIBUTION; BRAIN; CEREBROVASCULAR ACCIDENT; HEMISPHERIC DOMINANCE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; STROKE; TIME FACTORS;

EID: 77953621687     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.05.008     Document Type: Article

References (47)

1. Bak S., Sindrup S.H., Alslev T., Kristensen O., Christensen K., Gaist D. Cessation of smoking after first-ever stroke: a follow-up study. Stroke 2002, 33:2263-2269.
2. Ballard J., Kreiter K.T., Claassen J., Kowalski R.G., Connolly E.S., Mayer S.A. Risk factors for continued cigarette use after subarachnoid hemorrhage. Stroke 2003, 34:1859-1863.
3. Bamford J., Sandercock P., Dennis M., Burn J., Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526.
4. Bonson K.R., Grant S.J., Contoreggi C.S., Links J.M., Metcalfe J., Weyl H.L., Kurian V., Ernst M., London E.D. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 2002, 26:376-386.
5. Brott T., Marler J.R., Olinger C.P., Adams H.P., Tomsick T., Barsan W.G., Biller J., Eberle R., Hertzberg V., Walker M. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke 1989, 20:871-875.
6. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Exp. Rev. Cardiovasc. Ther. 2008, 6:883-895.
7. Burns D. Epidemiology of smoking-induced cardiovascular disease. Prog. Cardiovasc. Dis. 2003, 46:11-29.
8. Domino E.F., Minoshima S., Guthrie S.K., Ohl L., Ni L., Koeppe R.A., Cross D.J., Zubieta J. Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience 2000, 101:277-282.
9. Due D.L., Huettel S.A., Hall W.G., Rubin D.C. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am. J. Psychiatry 2002, 159:954-960.
10. Duffau H., Taillandier L., Gatignol P., Capelle L. The insular lobe and brain plasticity: lessons from tumor surgery. Clin. Neurol. Neurosurg. 2006, 108:543-548.
11. Glynn S.M., Gruder C.L., Jegerski J.A. Effects of biochemical validation of self-reported cigarette smoking on treatment success and on misreporting abstinence. Health Psychol. 1986, 5:125-136.
12. Goldstein L.B., Bertels C., Davis J.N. Interrater reliability of NIH Stroke Scale. Arch. Neurol. 1989, 46:660-662.
13. Gonzales D., Rennard S.I., Nides M., Oncken Ch., Azoulay S., Billing C.S., Watsky E.J., Gong J., Williams K.E. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006, 296:47-55. K.R. Reeves for the Varenicline Phase 3 Study Group.
14. Grandes G., Cortada J.M., Arrazola A., Laka J.P. Predictors of long-term outcome of a smoking cessation programme in primary care. Br. J. Gen. Pract. 2003, 53:101-107.
15. Diagnostic and Surgical Imaging Anatomy: Brain, Head and Neck, Spine 2006, Amirsys, Salt Lake City. R. Harnsberger, A. Osborn, A. MacDonald, J. Ross (Eds.).
16. Hatano S. Experience from a multicenter Stroke Registry: A Preliminary Report. Bull. World Health Organ. 1976, 54:541-553.
17. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
18. http://www.med.harvard.edu/AANLIB/cases/caseM/mr1_t/024.html.
19. Hymowitz N., Cummings K., Hyland A., Lynn W., Pechacek T., Hartwell T. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob. Control. 1997, 6(Suppl. 2):57-62.
20. Ives S.P., Heuschman P.U., Wolfe C.D., Redfern J. Patterns of smoking cessation in the first 3 years after stroke: the South London Stroke Register. Eur. J. Cardiovasc. Prev. Rehabil. 2008, 15:329-335.
21. Khurana S., Batra V., Patkar A.A., Leone F.T. Twenty-first century tobacco use: it is not just a risk factor anymore. Respir. Med. 2003, 97:295-301.
22. Kozlowski L.T., Porter C.Q., Orleans C.T., Pope M.A., Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend. 1994, 34:211-216.
23. Lee C.W., Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am. J. Public Health 2007, 97:1503-1509.
24. Lesch O.M., Dvorak A., Hertling I., Klingler A., Kunze M., Ramskogler K., Saletu-Zyhlarz G., Schoberberger R., Walter H. The Austrian multicentre study on smoking: subgroups of nicotine dependence and their craving. Neuropsychobiology 2004, 50:78-88.
25. Li C., Engström G., Hedblad B., Berglund G., Janzon L. Risk factors for stroke in subjects with normal blood pressure. A prospective cohort study. Stroke 2005, 36:234-238.
26. Mahoney F.D., Barthel D.W. Functional evaluation: the Barthel Index. Md. State Med. J. 1965, 14:61-63.
27. McBride D., Barrett S.P., Kelly J.T., Aw A., Dagher A. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. Neuropsychopharmacology 2006, 31:2728-2738.
28. Moeller T.B., Reif E. Pocket Atlas of Sectional Anatomy: Computed Tomography and Magnetic Resonance Imaging 2007, vol. 1. Thieme, Stuttgart, NY.
29. Nagai M., Kishi K., Kato S. Insular cortex and neuropsychiatric disorders: a review of recent literature. Eur. Psychiatry 2007, 22:387-394.
30. Nakamura H., Tanaka A., Nomoto Y., Ueno Y., Nakayama Y. Activation of fronto-limbic system in the human brain by cigarette smoking: evaluated by a CBF measurement. Keio J. Med. 2000, 49(Suppl. 1):1122-1124.
31. Naqvi N.H., Rudrauf D., Damasio H., Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science 2007, 315:531-534.
32. Okuyemi K.S., Nollen N.L., Ahluwalia J.S. Interventions to facilitate smoking cessation. Am. Fam. Physician 2006, 74:262-271.
33. N.I.H. Papamitsakis, Lacunar Syndromes, updated February 24, 2010, http://emedicine.medscape.com/article/1163029-overview.
34. Peto R., Lopez A.D., Boreham J., Thun M., Heath C. Mortality from Smoking in Developed Countries 1994, Oxford University Press, Oxford.
35. Quist-Paulsen P., Bakke P.S., Gallefoss F. Predictors of smoking cessation in patients admitted for acute coronary heart disease. Eur. J. Cardiovasc. Prev. Rehabil. 2005, 12:472-477.
36. Redfern J., McKevitt C., Dundas R., Rudd A.G., Wolfe C.D.A. Behavioral risk factor prevalence and lifestyle change after stroke: a prospective study. Stroke 2000, 31:1877-1881.
37. Rohr J., Kittner S., Feeser B., Hebel J.R., Whyte M.G., Weinstein A., Kanarak N., Buchholz D., Earley C., Johnson C., Macko R., Price T., Sloan M., Stern B., Wityk R., Wozniak M., Sherwin R. Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch. Neurol. 1996, 53:603-607.
38. L.R. Sauerbeck, J.C. Khoury, D. Woo, B.M. Kissela, C.J. Moomaw, J.P. Broderick, Smoking cessation after stroke: education and its effect on behavior, J. Neurosci. Nurs. 37 (2005) 316-319, 325.
39. Shinton R., Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br. Med. J. 1989, 298:789-794.
40. Sienkiewicz-Jarosz H., Zatorski P., Baranowska A., Ryglewicz D., Bienkowski P. Predictors of smoking abstinence after first-ever ischemic stroke: a 3-month follow-up. Stroke 2009, 40:2592-2593.
41. Sienkiewicz-Jarosz H., Zatorski P., Korkosz A., Ryglewicz D., Swiecicki L., Bienkowski P., Scinska A. Disruption of nicotine addiction associated with paroxysmal hypersomnia. J. Neuropsychiatry Clin. Neurosci. 2009, 21:342.
42. H. Sienkiewicz-Jarosz, P. Zatorski, G. Witkowski, A. Rogowski, A. Scinska, D. Ryglewicz, Predictors of smoking cessation after stroke, Neurol. Neuroch. Pol., 44 (2010) 181-187.
43. SRNT Subcommittee on Biochemical Verification Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002, 4:149-159.
44. Stein E.A., Pankiewicz J., Harsch H.H., Cho J.K., Fuller S.A., Hoffmann R.G., Hawkins M., Takahashi H., Fujimura Y., Hayashi M., Takano H., Kato M., Okubo Y., Kanno I., Ito H., Suhara T. Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study. Int. J. Neuropsychopharmacol. 2007, 22:1-5.
45. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee Guidelines for management of ischemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis. 2008, 25:457-507.
46. Wiebers D.O., Feigin V.L., Brown R.D. Handbook of Stroke 2006, Lippincott Williams & Wilkins (LWW).
47. Wolf P.A., Agostino R.B.D., Kannel W.B., Bonita R., Belanger A.J. Cigarettes smoking as a risk factor for stroke. The Framingham Study. JAMA 1988, 259:1025-1029.